Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES
GLOBETECH PUBLISHING LLC

Solid Media Used to Isolate Leptospira

By Labmedica International staff writers
Posted on 25 Feb 2013
Image: Leptospira interrogans (Photo courtesy of Science Photo Library).
Image: Leptospira interrogans (Photo courtesy of Science Photo Library).
Isolation of Leptospira, from clinical samples and testing of antimicrobial susceptibility are difficult and time-consuming.

Pathogenic Leptospira are slow-growing Gram-negative spirochetes and a new solid medium that facilitates more-rapid growth of these organisms has been developed

Microbiologists at the Mahidol University (Bangkok, Thailand) developed the new solid medium, called LVW agar, by testing the effects of combinations of ingredients and incubation conditions. All recipes contained three core ingredients and a variable concentration of two additional ingredients. A total of 109 pathogenic Leptospira isolates were used during the development and evaluation of the new solid medium and Etest, which is well-established method for antimicrobial resistance testing, antibiotic susceptibility testing in microbiology laboratories around the world.

The medium was developed by evaluating the effects of numerous factors on the growth rate of a strain of Leptospira interrogans. These included the type of base agar, the concentration of rabbit serum (RS), and the concentration and duration of carbon dioxide (CO2) incubation during the initial period of culture. The highest growth rate of this strain was achieved using a Noble agar base supplemented with 10% RS and named LVW agar, with an initial incubation at 30 °C in 5% CO2 for two days prior to continuous culture in air at 30 °C.

These conditions were used to develop the Etest for three species, L. interrogans, L. kirschnerii, and L. borgpetersenii. The minimum inhibitory concentrations (MICs) were read on day seven for all samples. The validated Etest methodology was performed for 109 Leptospira isolates with five antimicrobial drugs, penicillin G, doxycycline, ceftriaxone, cefotaxime, and chloramphenicol. The MIC90 values were as follows: penicillin G, 0.064 units/mL; doxycycline, 0.19 µg/mL; cefotaxime, 0.047 µg/mL; ceftriaxone, 0.5 µg/mL; and chloramphenicol, 2 µg/mL.

Leptospirosis is a zoonotic disease that has a worldwide distribution but has the greatest impact on health in developing countries, where it is often grossly under recognized. The authors concluded that LVW agar that enables rapid growth, isolation of single colonies, and simple antimicrobial susceptibility testing for Leptospira species will become widely used in diagnostic microbiology laboratories, but especially in resource-limited settings. The study was published in the January 2013 issue of the journal Antimicrobial Agents and Chemotherapy.

Related Links:

Mahidol University




DIASYS DIAGNOSTIC SYSTEMS
Dubai Bio Expo-2015
KARL HECHT GMBH & CO KG

Channels

Genetic Tests

view channel
Image: The final result of a DNA sequencing process, with each color representing one of the four base chemicals, adenine, guanine, cytosine and thymine, that comprise DNA (Photo courtesy of Gerald Barber).

Gene Sequencing Reference Standard Increases Accuracy for Medical Laboratories

To reduce the variability in genetic test results that has been observed across different clinical laboratories and pathology groups, a new standard DNA reference has been introduced, which will improve... Read more

Hematology

view channel
Image: Immunochemistry of bone marrow biopsy from an acute myeloid leukemia patient showing sheets of CD34 positive cells; corresponding bone marrow aspirate showed only 20% blasts (Photo courtesy of All India Institute of Medical Sciences).

Immunohistochemistry Assesses Early Response in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to prognosis and early response assessment has an established role as predictor of remission rate, and overall and disease-free survival.... Read more

Industry News

view channel

Partners to Develop and Commercialize Noninvasive Tests for Bladder Cancer

An agreement between a major European university medical center and a multinational biotechnology company was designed to promote commercialization and further development of a liquid biopsy test for the diagnosis of bladder cancer. The liquid biopsy test is based on bladder cancer DNA methylation biomarkers developed... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.